The Biopharma Congress is put on by the team at Prevision Policy, a continuous regulatory and policy information service for biopharma, and Friends of Cancer Research, a leading voice in advocating for policies that get treatments to patients in the safest, quickest way possible. 

Our partners are important in helping to make the Biopharma Congress a valuable experience for our attendees. 

LEAD SPONSOR

  The ADVI team is a strong, thoughtful, creative and highly collaborative group of healthcare executives, public policy alumni, and medical professionals from public and commercial payer settings, proven at identifying, creating, managing and realizing opportunities for transformational change, generating ideas or accelerating growth. Together, our people offer a rare combination of leadership experience, industry relationships, knowledge of the political and policy processes, reimbursement background, and transactional expertise to help our clients build true value in healthcare.

 

The ADVI team is a strong, thoughtful, creative and highly collaborative group of healthcare executives, public policy alumni, and medical professionals from public and commercial payer settings, proven at identifying, creating, managing and realizing opportunities for transformational change, generating ideas or accelerating growth. Together, our people offer a rare combination of leadership experience, industry relationships, knowledge of the political and policy processes, reimbursement background, and transactional expertise to help our clients build true value in healthcare.

 

SPONSORS


Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

Astellas Pharma US, Inc., is the U.S. affiliate of Astellas Pharma Inc., a R&D-driven global pharmaceutical company. At Astellas, we improve lives through innovative and effective medicines. Our dedication to changing tomorrow for patients and our customers fits closely with our strong scientific orientation and focus on the community in which we work and live.

Astellas Pharma US, Inc., is the U.S. affiliate of Astellas Pharma Inc., a R&D-driven global pharmaceutical company. At Astellas, we improve lives through innovative and effective medicines. Our dedication to changing tomorrow for patients and our customers fits closely with our strong scientific orientation and focus on the community in which we work and live.

 
  Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything we do, we aim to fulfill our mission to serve patients. And every step of the way, we are guided by the values that define us.

 

Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything we do, we aim to fulfill our mission to serve patients. And every step of the way, we are guided by the values that define us.

 
Clients typically engage PWR on complex, strategic challenges facing FDA regulated products for which PWR attorneys, scientists, communications and other experts develop and execute solutions. Expected contribution to patient and public health is key to PWR’s selection of new matters. The same criterion is used to identify the firm’s pro bono efforts.

Clients typically engage PWR on complex, strategic challenges facing FDA regulated products for which PWR attorneys, scientists, communications and other experts develop and execute solutions. Expected contribution to patient and public health is key to PWR’s selection of new matters. The same criterion is used to identify the firm’s pro bono efforts.


Become a Partner

If you would like to partner with us, fill out the form below and one of our staff members will get back to you.